Neurology Contract Research Organization Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East
Description
The global neurology contract research organization market size is likely to be valued at US$ 9.6 Bn in 2025 and is projected to reach US$ 15.5 Bn by 2032, growing at a CAGR of 7.08% during the forecast period. The rising burden of neurological disorders, coupled with increased outsourcing of R&D activities by pharmaceutical and biopharmaceutical firms, is accelerating the market growth. CROs are playing a critical role in optimizing time, cost, and operational efficiencies in conducting complex neuroscience trials, thereby boosting their demand worldwide.
Neurology Contract Research Organization Market – Report Scope:
The neurology contract research organization market encompasses a wide range of outsourced services, including clinical trials, data management, regulatory affairs, and pharmacovigilance, tailored specifically to neurological and neurodegenerative diseases. These CROs offer end-to-end support from early-phase development to late-stage trials, across various indications such as Alzheimer's disease, epilepsy, Parkinson’s disease, and brain tumors. The increasing complexity of neurology studies, stringent regulatory requirements, and rising focus on precision medicine are driving CROs to adopt innovative trial models and digital tools for enhanced outcomes.
Market Growth Drivers:
The global neurology CRO market is witnessing robust growth due to a surge in neurological disorders globally, including Alzheimer’s disease, epilepsy, and stroke. Rising R&D spending by pharmaceutical and biotech companies, driven by a growing need for effective central nervous system (CNS) therapeutics, has created strong demand for specialized CRO services. Moreover, increasing regulatory scrutiny has compelled sponsors to rely on experienced CROs to manage documentation, protocol development, and compliance requirements. Advancements in neuroimaging, biomarkers, and digital trial platforms are further accelerating clinical progress and trial efficiency.
Market Restraints:
Despite the growing demand, the neurology CRO market faces certain challenges. The high cost associated with conducting neurology trials, especially those requiring advanced imaging or long study durations, can deter smaller firms. Additionally, patient recruitment and retention remain complex in CNS trials due to stringent inclusion criteria and high dropout rates. The global shortage of neurologists and trained research professionals also affects trial timelines. Regulatory variability across regions and data privacy laws may further restrict market expansion in certain geographies.
Market Opportunities:
The market offers significant opportunities as neurodegenerative diseases become a central focus of innovation. The emergence of gene and cell therapies, along with novel therapeutic modalities for rare neurological conditions like CALD and PMA, opens new avenues for CRO involvement. Growing collaborations between academia and CROs to explore early-stage research and translational neuroscience are on the rise. Asia Pacific and Latin America present untapped potential due to rising clinical trial activity, cost advantages, and expanding patient pools. Furthermore, the integration of AI and machine learning into neurology trials is expected to revolutionize trial designs and predictive modeling.
Regional Outlook:
North America dominates the neurology CRO market due to its advanced healthcare infrastructure, significant R&D investments, and presence of leading pharmaceutical companies. The U.S. leads with the highest number of neurology trials, supported by favorable regulatory frameworks and increasing incidence of CNS disorders. Europe follows closely, driven by active clinical research ecosystems in countries like Germany, the UK, and France. Asia Pacific is emerging as a high-growth region, particularly India and China, owing to low-cost trial execution, expanding research capabilities, and growing interest from global sponsors. Latin America and the Middle East & Africa are also gradually advancing with improvements in regulatory landscapes and clinical infrastructure.
Leading Companies:
Key players in the global neurology contract research organization market are emphasizing innovation, strategic partnerships, and geographic expansion. Companies such as Charles River Laboratories, IQVIA Inc., Parexel International, and Medpace are investing in specialized neurology service portfolios. Others like Neuroservices Alliance and QPS Neuropharmacology offer highly tailored neuroscience-focused CRO services. Collaborations with academic research institutions, integration of AI tools, and expansion in emerging markets are central to their strategic growth.
Companies Covered in This Report:
• Charles River Laboratories
• Laboratory Corporation of America Holdings
• IQVIA Inc.
• Parexel International Corporation
• ICON plc.
• Medpace
• Syneos Health
• Thermo Fisher Scientific (PPD Inc.)
• Pharmaron Beijing Co., Ltd.
• Neuroservices Alliance
• QPS Neuropharmacology
• MD Biosciences
• CTI Clinical Trial and Consulting Services
• Atlantic Research Group, Inc.
• EphyX Neuroscience
• Ergomed PLC
• Neuron Experts
• Axon CRO
Market Segmentation:
By Service:
• Clinical Services
• Early Phase/Phase I Development
• Phase IIB-III Clinical Trials
• Phase IIIB-Phase IV Clinical Trials
• 510(k), IDE, IND, PMA, De Novo, Retrospective Clinical Studies
• Data Management & Biostatistics
• Drug Safety
• Medical and Scientific Writing
• Regulatory Affairs
• Pharmacology and Toxicology
• Quality and Compliance
By Study Type:
• Neuroscience Focused
• Neurology Focused
By Indication:
• Alzheimer’s Disease
• Brain Tumors
• Epilepsy & Seizures
• Headaches
• Schizophrenia
• Depressive Disorder
• Multiple Sclerosis (MS)
• Muscular Dystrophy
• Parkinson’s Disease
• Progressive Muscular Atrophy (PMA)
• Stroke
• Psychiatry
• Autism Spectrum Disorder
• Cerebral Adrenoleukodystrophy (CALD)
• Sleep Apnea/Sleep Dysfunction
By End User:
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic and Research Institutes
By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Please note: Delivery Timelines - 5 working days.
Neurology Contract Research Organization Market – Report Scope:
The neurology contract research organization market encompasses a wide range of outsourced services, including clinical trials, data management, regulatory affairs, and pharmacovigilance, tailored specifically to neurological and neurodegenerative diseases. These CROs offer end-to-end support from early-phase development to late-stage trials, across various indications such as Alzheimer's disease, epilepsy, Parkinson’s disease, and brain tumors. The increasing complexity of neurology studies, stringent regulatory requirements, and rising focus on precision medicine are driving CROs to adopt innovative trial models and digital tools for enhanced outcomes.
Market Growth Drivers:
The global neurology CRO market is witnessing robust growth due to a surge in neurological disorders globally, including Alzheimer’s disease, epilepsy, and stroke. Rising R&D spending by pharmaceutical and biotech companies, driven by a growing need for effective central nervous system (CNS) therapeutics, has created strong demand for specialized CRO services. Moreover, increasing regulatory scrutiny has compelled sponsors to rely on experienced CROs to manage documentation, protocol development, and compliance requirements. Advancements in neuroimaging, biomarkers, and digital trial platforms are further accelerating clinical progress and trial efficiency.
Market Restraints:
Despite the growing demand, the neurology CRO market faces certain challenges. The high cost associated with conducting neurology trials, especially those requiring advanced imaging or long study durations, can deter smaller firms. Additionally, patient recruitment and retention remain complex in CNS trials due to stringent inclusion criteria and high dropout rates. The global shortage of neurologists and trained research professionals also affects trial timelines. Regulatory variability across regions and data privacy laws may further restrict market expansion in certain geographies.
Market Opportunities:
The market offers significant opportunities as neurodegenerative diseases become a central focus of innovation. The emergence of gene and cell therapies, along with novel therapeutic modalities for rare neurological conditions like CALD and PMA, opens new avenues for CRO involvement. Growing collaborations between academia and CROs to explore early-stage research and translational neuroscience are on the rise. Asia Pacific and Latin America present untapped potential due to rising clinical trial activity, cost advantages, and expanding patient pools. Furthermore, the integration of AI and machine learning into neurology trials is expected to revolutionize trial designs and predictive modeling.
Regional Outlook:
North America dominates the neurology CRO market due to its advanced healthcare infrastructure, significant R&D investments, and presence of leading pharmaceutical companies. The U.S. leads with the highest number of neurology trials, supported by favorable regulatory frameworks and increasing incidence of CNS disorders. Europe follows closely, driven by active clinical research ecosystems in countries like Germany, the UK, and France. Asia Pacific is emerging as a high-growth region, particularly India and China, owing to low-cost trial execution, expanding research capabilities, and growing interest from global sponsors. Latin America and the Middle East & Africa are also gradually advancing with improvements in regulatory landscapes and clinical infrastructure.
Leading Companies:
Key players in the global neurology contract research organization market are emphasizing innovation, strategic partnerships, and geographic expansion. Companies such as Charles River Laboratories, IQVIA Inc., Parexel International, and Medpace are investing in specialized neurology service portfolios. Others like Neuroservices Alliance and QPS Neuropharmacology offer highly tailored neuroscience-focused CRO services. Collaborations with academic research institutions, integration of AI tools, and expansion in emerging markets are central to their strategic growth.
Companies Covered in This Report:
• Charles River Laboratories
• Laboratory Corporation of America Holdings
• IQVIA Inc.
• Parexel International Corporation
• ICON plc.
• Medpace
• Syneos Health
• Thermo Fisher Scientific (PPD Inc.)
• Pharmaron Beijing Co., Ltd.
• Neuroservices Alliance
• QPS Neuropharmacology
• MD Biosciences
• CTI Clinical Trial and Consulting Services
• Atlantic Research Group, Inc.
• EphyX Neuroscience
• Ergomed PLC
• Neuron Experts
• Axon CRO
Market Segmentation:
By Service:
• Clinical Services
• Early Phase/Phase I Development
• Phase IIB-III Clinical Trials
• Phase IIIB-Phase IV Clinical Trials
• 510(k), IDE, IND, PMA, De Novo, Retrospective Clinical Studies
• Data Management & Biostatistics
• Drug Safety
• Medical and Scientific Writing
• Regulatory Affairs
• Pharmacology and Toxicology
• Quality and Compliance
By Study Type:
• Neuroscience Focused
• Neurology Focused
By Indication:
• Alzheimer’s Disease
• Brain Tumors
• Epilepsy & Seizures
• Headaches
• Schizophrenia
• Depressive Disorder
• Multiple Sclerosis (MS)
• Muscular Dystrophy
• Parkinson’s Disease
• Progressive Muscular Atrophy (PMA)
• Stroke
• Psychiatry
• Autism Spectrum Disorder
• Cerebral Adrenoleukodystrophy (CALD)
• Sleep Apnea/Sleep Dysfunction
By End User:
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic and Research Institutes
By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Please note: Delivery Timelines - 5 working days.
Table of Contents
257 Pages
- 1. Executive Summary
- 1.1. Global Neurology Contract Research Organization Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2023
- 1.5. Analyst Recommendations
- 2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. Porter’s Five Forces Analysis
- 2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
- 2.6. Impact of Ukraine-Russia Conflict
- 2.7. Economic Overview
- 2.7.1. World Economic Projections
- 2.8. PESTLE Analysis
- 3. Global Neurology Contract Research Organization Market Outlook, 2018 – 2031
- 3.1. Global Neurology Contract Research Organization Market Outlook, by Service, Value (US$ Bn), 2018 – 2031
- 3.1.1. Key Highlights
- 3.1.1.1. Clinical Services
- 3.1.1.1.1. Early Phase/Phase I Development
- 3.1.1.1.2. Phase IIB-III Clinical Trials
- 3.1.1.1.3. Phase IIIB-Phase IV Clinical Trials
- 3.1.1.1.4. 510(k) Clinical Studies
- 3.1.1.1.5. IDE Clinical Studies
- 3.1.1.1.6. IND Clinical Studies
- 3.1.1.1.7. PMA Clinical Studies
- 3.1.1.1.8. De Novo Clinical Studies
- 3.1.1.1.9. Retrospective Clinical Studies
- 3.1.1.2. Data Management Services
- 3.1.1.2.1. Clinical Database Selection
- 3.1.1.2.2. Clinical Study Planning and Clinical Protocol Development
- 3.1.1.2.3. Clinical Site Budget Development
- 3.1.1.2.4. Data Management (DM) and Biostatistics (BS)
- 3.1.1.3. Drug Safety
- 3.1.1.4. Medical and Scientific Writing
- 3.1.1.5. Regulatory Affairs
- 3.1.1.6. Pharmacology and Toxicology
- 3.1.1.7. Quality and Compliance
- 3.2. Global Neurology Contract Research Organization Market Outlook, by Study, Value (US$ Bn), 2018 – 2031
- 3.2.1. Key Highlights
- 3.2.1.1. Neuroscience focused.
- 3.2.1.2. Neurology focused.
- 3.3. Global Neurology Contract Research Organization Market Outlook, by Indication, Value (US$ Bn), 2018 – 2031
- 3.3.1. Key Highlights
- 3.3.1.1. Alzheimer's Disease
- 3.3.1.2. Brain Tumors
- 3.3.1.3. Epilepsy & Seizures
- 3.3.1.4. Headaches
- 3.3.1.5. Schizophrenia
- 3.3.1.6. Depressive Disorder
- 3.3.1.7. Multiple Sclerosis (MS)
- 3.3.1.8. Muscular Dystrophy
- 3.3.1.9. Parkinson's Disease
- 3.3.1.10. Progressive Muscular Atrophy (PMA)
- 3.3.1.11. Stroke
- 3.3.1.12. Psychiatry
- 3.3.1.13. Autism Spectrum Disorder
- 3.3.1.14. Cerebral Adrenoleukodystrophy (CALD)
- 3.3.1.15. Sleep Apnea/ Sleep Dysfunction
- 3.4. Global Neurology Contract Research Organization Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
- 3.4.1. Key Highlights
- 3.4.1.1. Pharmaceutical & Biopharmaceutical Companies
- 3.4.1.2. Biopharmaceutical Companies
- 3.4.1.3. Medical Device Companies
- 3.4.1.4. Academic and Research Institutes
- 3.5. Global Neurology Contract Research Organization Market Outlook, by Region, Value (US$ Bn), 2018 – 2031
- 3.5.1. Key Highlights
- 3.5.1.1. North America
- 3.5.1.2. Europe
- 3.5.1.3. Asia Pacific
- 3.5.1.4. Latin America
- 3.5.1.5. Middle East & Africa
- 4. North America Neurology Contract Research Organization Market Outlook, 2018 – 2031
- 4.1. North America Neurology Contract Research Organization Market Outlook, by Service, Value (US$ Bn), 2018 – 2031
- 4.1.1. Key Highlights
- 4.1.1.1. Clinical Services
- 4.1.1.1.1. Early Phase/Phase I Development
- 4.1.1.1.2. Phase IIB-III Clinical Trials
- 4.1.1.1.3. Phase IIIB-Phase IV Clinical Trials
- 4.1.1.1.4. 510(k) Clinical Studies
- 4.1.1.1.5. IDE Clinical Studies
- 4.1.1.1.6. IND Clinical Studies
- 4.1.1.1.7. PMA Clinical Studies
- 4.1.1.1.8. De Novo Clinical Studies
- 4.1.1.1.9. Retrospective Clinical Studies
- 4.1.1.2. Data Management Services
- 4.1.1.2.1. Clinical Database Selection
- 4.1.1.2.2. Clinical Study Planning and Clinical Protocol Development
- 4.1.1.2.3. Clinical Site Budget Development
- 4.1.1.2.4. Data Management (DM) and Biostatistics (BS)
- 4.1.1.3. Drug Safety
- 4.1.1.4. Medical and Scientific Writing
- 4.1.1.5. Regulatory Affairs
- 4.1.1.6. Pharmacology and Toxicology
- 4.1.1.7. Quality and Compliance
- 4.2. North America Neurology Contract Research Organization Market Outlook, by Study, Value (US$ Bn), 2018 – 2031
- 4.2.1. Key Highlights
- 4.2.1.1. Neuroscience focused.
- 4.2.1.2. Neurology focused.
- 4.3. North America Neurology Contract Research Organization Market Outlook, by Indication, Value (US$ Bn), 2018 – 2031
- 4.3.1. Key Highlights
- 4.3.1.1. Alzheimer's Disease
- 4.3.1.2. Brain Tumors
- 4.3.1.3. Epilepsy & Seizures
- 4.3.1.4. Headaches
- 4.3.1.5. Schizophrenia
- 4.3.1.6. Depressive Disorder
- 4.3.1.7. Multiple Sclerosis (MS)
- 4.3.1.8. Muscular Dystrophy
- 4.3.1.9. Parkinson's Disease
- 4.3.1.10. Progressive Muscular Atrophy (PMA)
- 4.3.1.11. Stroke
- 4.3.1.12. Psychiatry
- 4.3.1.13. Autism Spectrum Disorder
- 4.3.1.14. Cerebral Adrenoleukodystrophy (CALD)
- 4.3.1.15. Sleep Apnea/ Sleep Dysfunction
- 4.4. North America Neurology Contract Research Organization Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
- 4.4.1. Key Highlights
- 4.4.1.1. Pharmaceutical & Biopharmaceutical Companies
- 4.4.1.2. Biopharmaceutical Companies
- 4.4.1.3. Medical Device Companies
- 4.4.1.4. Academic and Research Institutes
- 4.5. North America Neurology Contract Research Organization Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 4.5.1. Key Highlights
- 4.5.1.1. U.S. Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 4.5.1.2. U.S. Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 4.5.1.3. U.S. Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 4.5.1.4. U.S. Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 4.5.1.5. Canada Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 4.5.1.6. Canada Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 4.5.1.7. Canada Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 4.5.1.8. Canada Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis
- 5. Europe Neurology Contract Research Organization Market Outlook, 2018 – 2031
- 5.1. Europe Neurology Contract Research Organization Market Outlook, by Service, Value (US$ Bn), 2018 – 2031
- 5.1.1. Key Highlights
- 5.1.1.1. Clinical Services
- 5.1.1.1.1. Early Phase/Phase I Development
- 5.1.1.1.2. Phase IIB-III Clinical Trials
- 5.1.1.1.3. Phase IIIB-Phase IV Clinical Trials
- 5.1.1.1.4. 510(k) Clinical Studies
- 5.1.1.1.5. IDE Clinical Studies
- 5.1.1.1.6. IND Clinical Studies
- 5.1.1.1.7. PMA Clinical Studies
- 5.1.1.1.8. De Novo Clinical Studies
- 5.1.1.1.9. Retrospective Clinical Studies
- 5.1.1.2. Data Management Services
- 5.1.1.2.1. Clinical Database Selection
- 5.1.1.2.2. Clinical Study Planning and Clinical Protocol Development
- 5.1.1.2.3. Clinical Site Budget Development
- 5.1.1.2.4. Data Management (DM) and Biostatistics (BS)
- 5.1.1.3. Drug Safety
- 5.1.1.4. Medical and Scientific Writing
- 5.1.1.5. Regulatory Affairs
- 5.1.1.6. Pharmacology and Toxicology
- 5.1.1.7. Quality and Compliance
- 5.2. Europe Neurology Contract Research Organization Market Outlook, by Study, Value (US$ Bn), 2018 – 2031
- 5.2.1. Key Highlights
- 5.2.1.1. Neuroscience focused.
- 5.2.1.2. Neurology focused.
- 5.3. Europe Neurology Contract Research Organization Market Outlook, by Indication, Value (US$ Bn), 2018 – 2031
- 5.3.1. Key Highlights
- 5.3.1.1. Alzheimer's Disease
- 5.3.1.2. Brain Tumors
- 5.3.1.3. Epilepsy & Seizures
- 5.3.1.4. Headaches
- 5.3.1.5. Schizophrenia
- 5.3.1.6. Depressive Disorder
- 5.3.1.7. Multiple Sclerosis (MS)
- 5.3.1.8. Muscular Dystrophy
- 5.3.1.9. Parkinson's Disease
- 5.3.1.10. Progressive Muscular Atrophy (PMA)
- 5.3.1.11. Stroke
- 5.3.1.12. Psychiatry
- 5.3.1.13. Autism Spectrum Disorder
- 5.3.1.14. Cerebral Adrenoleukodystrophy (CALD)
- 5.3.1.15. Sleep Apnea/ Sleep Dysfunction
- 5.4. Europe Neurology Contract Research Organization Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
- 5.4.1. Key Highlights
- 5.4.1.1. Pharmaceutical & Biopharmaceutical Companies
- 5.4.1.2. Biopharmaceutical Companies
- 5.4.1.3. Medical Device Companies
- 5.4.1.4. Academic and Research Institutes
- 5.5. Europe Neurology Contract Research Organization Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 5.5.1. Key Highlights
- 5.5.1.1. Germany Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 5.5.1.2. Germany Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 5.5.1.3. Germany Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.4. Germany Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 5.5.1.5. U.K. Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 5.5.1.6. U.K. Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 5.5.1.7. U.K. Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.8. U.K. Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 5.5.1.9. France Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 5.5.1.10. France Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 5.5.1.11. France Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.12. France Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 5.5.1.13. Italy Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 5.5.1.14. Italy Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 5.5.1.15. Italy Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.16. Italy Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 5.5.1.17. Turkey Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 5.5.1.18. Turkey Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 5.5.1.19. Turkey Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.20. Turkey Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 5.5.1.21. Russia Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 5.5.1.22. Russia Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 5.5.1.23. Russia Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.24. Russia Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 5.5.1.25. Rest of Europe Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 5.5.1.26. Rest of Europe Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 5.5.1.27. Rest of Europe Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.28. Rest of Europe Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis
- 6. Asia Pacific Neurology Contract Research Organization Market Outlook, 2018 – 2031
- 6.1. Asia Pacific Neurology Contract Research Organization Market Outlook, by Service, Value (US$ Bn), 2018 – 2031
- 6.1.1. Key Highlights
- 6.1.1.1. Clinical Services
- 6.1.1.1.1. Early Phase/Phase I Development
- 6.1.1.1.2. Phase IIB-III Clinical Trials
- 6.1.1.1.3. Phase IIIB-Phase IV Clinical Trials
- 6.1.1.1.4. 510(k) Clinical Studies
- 6.1.1.1.5. IDE Clinical Studies
- 6.1.1.1.6. IND Clinical Studies
- 6.1.1.1.7. PMA Clinical Studies
- 6.1.1.1.8. De Novo Clinical Studies
- 6.1.1.1.9. Retrospective Clinical Studies
- 6.1.1.2. Data Management Services
- 6.1.1.2.1. Clinical Database Selection
- 6.1.1.2.2. Clinical Study Planning and Clinical Protocol Development
- 6.1.1.2.3. Clinical Site Budget Development
- 6.1.1.2.4. Data Management (DM) and Biostatistics (BS)
- 6.1.1.3. Drug Safety
- 6.1.1.4. Medical and Scientific Writing
- 6.1.1.5. Regulatory Affairs
- 6.1.1.6. Pharmacology and Toxicology
- 6.1.1.7. Quality and Compliance
- 6.2. Asia Pacific Neurology Contract Research Organization Market Outlook, by Study, Value (US$ Bn), 2018 – 2031
- 6.2.1. Key Highlights
- 6.2.1.1. Neuroscience focused.
- 6.2.1.2. Neurology focused.
- 6.3. Asia Pacific Neurology Contract Research Organization Market Outlook, by Indication, Value (US$ Bn), 2018 – 2031
- 6.3.1. Key Highlights
- 6.3.1.1. Alzheimer's Disease
- 6.3.1.2. Brain Tumors
- 6.3.1.3. Epilepsy & Seizures
- 6.3.1.4. Headaches
- 6.3.1.5. Schizophrenia
- 6.3.1.6. Depressive Disorder
- 6.3.1.7. Multiple Sclerosis (MS)
- 6.3.1.8. Muscular Dystrophy
- 6.3.1.9. Parkinson's Disease
- 6.3.1.10. Progressive Muscular Atrophy (PMA)
- 6.3.1.11. Stroke
- 6.3.1.12. Psychiatry
- 6.3.1.13. Autism Spectrum Disorder
- 6.3.1.14. Cerebral Adrenoleukodystrophy (CALD)
- 6.3.1.15. Sleep Apnea/ Sleep Dysfunction
- 6.4. Asia Pacific Neurology Contract Research Organization Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
- 6.4.1. Key Highlights
- 6.4.1.1. Pharmaceutical & Biopharmaceutical Companies
- 6.4.1.2. Biopharmaceutical Companies
- 6.4.1.3. Medical Device Companies
- 6.4.1.4. Academic and Research Institutes
- 6.5. Asia Pacific Neurology Contract Research Organization Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 6.5.1. Key Highlights
- 6.5.1.1. China Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 6.5.1.2. China Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 6.5.1.3. China Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.4. China Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 6.5.1.5. Japan Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 6.5.1.6. Japan Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 6.5.1.7. Japan Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.8. Japan Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 6.5.1.9. South Korea Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 6.5.1.10. South Korea Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 6.5.1.11. South Korea Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.12. South Korea Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 6.5.1.13. India Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 6.5.1.14. India Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 6.5.1.15. India Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.16. India Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 6.5.1.17. Southeast Asia Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 6.5.1.18. Southeast Asia Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 6.5.1.19. Southeast Asia Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.20. Southeast Asia Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 6.5.1.21. Rest of Asia Pacific Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 6.5.1.22. Rest of Asia Pacific Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 6.5.1.23. Rest of Asia Pacific Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.24. Rest of Asia Pacific Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis
- 7. Latin America Neurology Contract Research Organization Market Outlook, 2018 – 2031
- 7.1. Latin America Neurology Contract Research Organization Market Outlook, by Service, Value (US$ Bn), 2018 – 2031
- 7.1.1. Key Highlights
- 7.1.1.1. Clinical Services
- 7.1.1.1.1. Early Phase/Phase I Development
- 7.1.1.1.2. Phase IIB-III Clinical Trials
- 7.1.1.1.3. Phase IIIB-Phase IV Clinical Trials
- 7.1.1.1.4. 510(k) Clinical Studies
- 7.1.1.1.5. IDE Clinical Studies
- 7.1.1.1.6. IND Clinical Studies
- 7.1.1.1.7. PMA Clinical Studies
- 7.1.1.1.8. De Novo Clinical Studies
- 7.1.1.1.9. Retrospective Clinical Studies
- 7.1.1.2. Data Management Services
- 7.1.1.2.1. Clinical Database Selection
- 7.1.1.2.2. Clinical Study Planning and Clinical Protocol Development
- 7.1.1.2.3. Clinical Site Budget Development
- 7.1.1.2.4. Data Management (DM) and Biostatistics (BS)
- 7.1.1.3. Drug Safety
- 7.1.1.4. Medical and Scientific Writing
- 7.1.1.5. Regulatory Affairs
- 7.1.1.6. Pharmacology and Toxicology
- 7.1.1.7. Quality and Compliance
- 7.2. Latin America Neurology Contract Research Organization Market Outlook, by Study, Value (US$ Bn), 2018 – 2031
- 7.2.1. Key Highlights
- 7.2.1.1. Neuroscience focused.
- 7.2.1.2. Neurology focused.
- 7.3. Latin America Neurology Contract Research Organization Market Outlook, by Indication, Value (US$ Bn), 2018 – 2031
- 7.3.1. Key Highlights
- 7.3.1.1. Alzheimer's Disease
- 7.3.1.2. Brain Tumors
- 7.3.1.3. Epilepsy & Seizures
- 7.3.1.4. Headaches
- 7.3.1.5. Schizophrenia
- 7.3.1.6. Depressive Disorder
- 7.3.1.7. Multiple Sclerosis (MS)
- 7.3.1.8. Muscular Dystrophy
- 7.3.1.9. Parkinson's Disease
- 7.3.1.10. Progressive Muscular Atrophy (PMA)
- 7.3.1.11. Stroke
- 7.3.1.12. Psychiatry
- 7.3.1.13. Autism Spectrum Disorder
- 7.3.1.14. Cerebral Adrenoleukodystrophy (CALD)
- 7.3.1.15. Sleep Apnea/ Sleep Dysfunction
- 7.4. Latin America Neurology Contract Research Organization Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
- 7.4.1. Key Highlights
- 7.4.1.1. Pharmaceutical & Biopharmaceutical Companies
- 7.4.1.2. Biopharmaceutical Companies
- 7.4.1.3. Medical Device Companies
- 7.4.1.4. Academic and Research Institutes
- 7.5. Latin America Neurology Contract Research Organization Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 7.5.1. Key Highlights
- 7.5.1.1. Brazil Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 7.5.1.2. Brazil Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 7.5.1.3. Brazil Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.4. Brazil Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 7.5.1.5. Mexico Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 7.5.1.6. Mexico Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 7.5.1.7. Mexico Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.8. Mexico Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 7.5.1.9. Argentina Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 7.5.1.10. Argentina Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 7.5.1.11. Argentina Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.12. Argentina Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 7.5.1.13. Rest of Latin America Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 7.5.1.14. Rest of Latin America Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 7.5.1.15. Rest of Latin America Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.16. Rest of Latin America Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis
- 8. Middle East & Africa Neurology Contract Research Organization Market Outlook, 2018 – 2031
- 8.1. Middle East & Africa Neurology Contract Research Organization Market Outlook, by Service, Value (US$ Bn), 2018 – 2031
- 8.1.1. Key Highlights
- 8.1.1.1. Clinical Services
- 8.1.1.1.1. Early Phase/Phase I Development
- 8.1.1.1.2. Phase IIB-III Clinical Trials
- 8.1.1.1.3. Phase IIIB-Phase IV Clinical Trials
- 8.1.1.1.4. 510(k) Clinical Studies
- 8.1.1.1.5. IDE Clinical Studies
- 8.1.1.1.6. IND Clinical Studies
- 8.1.1.1.7. PMA Clinical Studies
- 8.1.1.1.8. De Novo Clinical Studies
- 8.1.1.1.9. Retrospective Clinical Studies
- 8.1.1.2. Data Management Services
- 8.1.1.2.1. Clinical Database Selection
- 8.1.1.2.2. Clinical Study Planning and Clinical Protocol Development
- 8.1.1.2.3. Clinical Site Budget Development
- 8.1.1.2.4. Data Management (DM) and Biostatistics (BS)
- 8.1.1.3. Drug Safety
- 8.1.1.4. Medical and Scientific Writing
- 8.1.1.5. Regulatory Affairs
- 8.1.1.6. Pharmacology and Toxicology
- 8.1.1.7. Quality and Compliance
- 8.2. Middle East & Africa Neurology Contract Research Organization Market Outlook, by Study, Value (US$ Bn), 2018 – 2031
- 8.2.1. Key Highlights
- 8.2.1.1. Neuroscience focused.
- 8.2.1.2. Neurology focused.
- 8.3. Middle East & Africa Neurology Contract Research Organization Market Outlook, by Indication, Value (US$ Bn), 2018 – 2031
- 8.3.1. Key Highlights
- 8.3.1.1. Alzheimer's Disease
- 8.3.1.2. Brain Tumors
- 8.3.1.3. Epilepsy & Seizures
- 8.3.1.4. Headaches
- 8.3.1.5. Schizophrenia
- 8.3.1.6. Depressive Disorder
- 8.3.1.7. Multiple Sclerosis (MS)
- 8.3.1.8. Muscular Dystrophy
- 8.3.1.9. Parkinson's Disease
- 8.3.1.10. Progressive Muscular Atrophy (PMA)
- 8.3.1.11. Stroke
- 8.3.1.12. Psychiatry
- 8.3.1.13. Autism Spectrum Disorder
- 8.3.1.14. Cerebral Adrenoleukodystrophy (CALD)
- 8.3.1.15. Sleep Apnea/ Sleep Dysfunction
- 8.4. Middle East & Africa Neurology Contract Research Organization Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
- 8.4.1. Key Highlights
- 8.4.1.1. Pharmaceutical & Biopharmaceutical Companies
- 8.4.1.2. Biopharmaceutical Companies
- 8.4.1.3. Medical Device Companies
- 8.4.1.4. Academic and Research Institutes
- 8.5. Middle East & Africa Neurology Contract Research Organization Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 8.5.1. Key Highlights
- 8.5.1.1. GCC Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 8.5.1.2. GCC Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 8.5.1.3. GCC Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.4. GCC Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 8.5.1.5. South Africa Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 8.5.1.6. South Africa Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 8.5.1.7. South Africa Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.8. South Africa Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 8.5.1.9. Egypt Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 8.5.1.10. Egypt Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 8.5.1.11. Egypt Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.12. Egypt Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 8.5.1.13. Nigeria Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 8.5.1.14. Nigeria Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 8.5.1.15. Nigeria Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.16. Nigeria Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 8.5.1.17. Rest of Middle East & Africa Neurology Contract Research Organization Market by Service, Value (US$ Bn), 2018 – 2031
- 8.5.1.18. Rest of Middle East & Africa Neurology Contract Research Organization Market Indication, Value (US$ Bn), 2018 – 2031
- 8.5.1.19. Rest of Middle East & Africa Neurology Contract Research Organization Market Artery Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.20. Rest of Middle East & Africa Neurology Contract Research Organization Market End User, Value (US$ Bn), 2018 – 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis
- 9. Competitive Landscape
- 9.1. Artery Type vs Indication Heatmap
- 9.2. Manufacturer vs Indication Heatmap
- 9.3. Company Market Share Analysis, 2023
- 9.4. Competitive Dashboard
- 9.5. Company Profiles
- 9.5.1. Charles River Laboratories
- 9.5.1.1. Company Overview
- 9.5.1.2. Product Portfolio
- 9.5.1.3. Financial Overview
- 9.5.1.4. Business Strategies and Development
- 9.5.2. Laboratory Corporation of America Holdings
- 9.5.2.1. Company Overview
- 9.5.2.2. Product Portfolio
- 9.5.2.3. Financial Overview
- 9.5.2.4. Business Strategies and Development
- 9.5.3. IQVIA Inc.
- 9.5.3.1. Company Overview
- 9.5.3.2. Product Portfolio
- 9.5.3.3. Financial Overview
- 9.5.3.4. Business Strategies and Development
- 9.5.4. Syneos Health
- 9.5.4.1. Company Overview
- 9.5.4.2. Product Portfolio
- 9.5.4.3. Financial Overview
- 9.5.4.4. Business Strategies and Development
- 9.5.5. Parexel International Corporation
- 9.5.5.1. Company Overview
- 9.5.5.2. Product Portfolio
- 9.5.5.3. Financial Overview
- 9.5.5.4. Business Strategies and Development
- 9.5.6. ICON Plc.
- 9.5.6.1. Company Overview
- 9.5.6.2. Product Portfolio
- 9.5.6.3. Financial Overview
- 9.5.6.4. Business Strategies and Development
- 9.5.7. Medpace
- 9.5.7.1. Company Overview
- 9.5.7.2. Product Portfolio
- 9.5.7.3. Financial Overview
- 9.5.7.4. Business Strategies and Development
- 9.5.8. Axon CRO
- 9.5.8.1. Company Overview
- 9.5.8.2. Product Portfolio
- 9.5.8.3. Financial Overview
- 9.5.8.4. Business Strategies and Development
- 9.5.9. Thermo Fisher Scientific Inc. (PPD Inc.)
- 9.5.9.1. Company Overview
- 9.5.9.2. Product Portfolio
- 9.5.9.3. Financial Overview
- 9.5.9.4. Business Strategies and Development
- 9.5.10. CTI Clinical Trial & Consulting
- 9.5.10.1. Company Overview
- 9.5.10.2. Product Portfolio
- 9.5.10.3. Financial Overview
- 9.5.10.4. Business Strategies and Development
- 9.5.11. Pharmaron Beijing Co., Ltd.
- 9.5.11.1. Company Overview
- 9.5.11.2. Product Portfolio
- 9.5.11.3. Financial Overview
- 9.5.11.4. Business Strategies and Development
- 9.5.12. Neuroservices-Alliance
- 9.5.12.1. Company Overview
- 9.5.12.2. Product Portfolio
- 9.5.12.3. Financial Overview
- 9.5.12.4. Business Strategies and Development
- 9.5.13. QPS Neuropharmacology
- 9.5.13.1. Company Overview
- 9.5.13.2. Product Portfolio
- 9.5.13.3. Financial Overview
- 9.5.13.4. Business Strategies and Development
- 9.5.14. MD Biosciences
- 9.5.14.1. Company Overview
- 9.5.14.2. Product Portfolio
- 9.5.14.3. Financial Overview
- 9.5.14.4. Business Strategies and Development
- 9.5.15. Atlantic Research Group, Inc.
- 9.5.15.1. Company Overview
- 9.5.15.2. Product Portfolio
- 9.5.15.3. Financial Overview
- 9.5.15.4. Business Strategies and Development
- 9.5.16. EphyX Neuroscience
- 9.5.16.1. Company Overview
- 9.5.16.2. Product Portfolio
- 9.5.16.3. Financial Overview
- 9.5.16.4. Business Strategies and Development
- 9.5.17. Ergomed plc
- 9.5.17.1. Company Overview
- 9.5.17.2. Product Portfolio
- 9.5.17.3. Financial Overview
- 9.5.17.4. Business Strategies and Development
- 9.5.18. Neuron Experts
- 9.5.18.1. Company Overview
- 9.5.18.2. Product Portfolio
- 9.5.18.3. Financial Overview
- 9.5.18.4. Business Strategies and Development
- 10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
